These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 17590546)
1. Vitrification from solution in restricted space: formation and stabilization of amorphous nifedipine in a nanoporous silica xerogel carrier. Godec A; Maver U; Bele M; Planinsek O; Srcic S; Gaberscek M; Jamnik J Int J Pharm; 2007 Oct; 343(1-2):131-40. PubMed ID: 17590546 [TBL] [Abstract][Full Text] [Related]
2. Novel hybrid silica xerogels for stabilization and controlled release of drug. Maver U; Godec A; Bele M; Planinsek O; Gaberscek M; Srcic S; Jamnik J Int J Pharm; 2007 Feb; 330(1-2):164-74. PubMed ID: 17055199 [TBL] [Abstract][Full Text] [Related]
3. Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method. Takeuchi H; Nagira S; Yamamoto H; Kawashima Y Int J Pharm; 2005 Apr; 293(1-2):155-64. PubMed ID: 15778053 [TBL] [Abstract][Full Text] [Related]
4. Characterisation of indomethacin and nifedipine using variable-temperature solid-state NMR. Apperley DC; Forster AH; Fournier R; Harris RK; Hodgkinson P; Lancaster RW; Rades T Magn Reson Chem; 2005 Nov; 43(11):881-92. PubMed ID: 16059964 [TBL] [Abstract][Full Text] [Related]
5. Stability of amorphous drug, 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2H-pyridazin-3-one, in silica mesopores and measurement of its molecular mobility by solid-state (13)C NMR spectroscopy. Miura H; Kanebako M; Shirai H; Nakao H; Inagi T; Terada K Int J Pharm; 2011 May; 410(1-2):61-7. PubMed ID: 21421036 [TBL] [Abstract][Full Text] [Related]
6. Solid dispersion of spironolactone with porous silica prepared by the solvent method. Uchino T; Yasuno N; Yanagihara Y; Suzuki H Pharmazie; 2007 Aug; 62(8):599-603. PubMed ID: 17867555 [TBL] [Abstract][Full Text] [Related]
7. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy. Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816 [TBL] [Abstract][Full Text] [Related]
8. 2H-solid state NMR and DSC study of isobutyric acid in mesoporous silica materials. Vyalikh A; Emmler T; Shenderovich I; Zeng Y; Findenegg GH; Buntkowsky G Phys Chem Chem Phys; 2007 Jun; 9(18):2249-57. PubMed ID: 17487322 [TBL] [Abstract][Full Text] [Related]
9. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. Rumondor AC; Marsac PJ; Stanford LA; Taylor LS Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917 [TBL] [Abstract][Full Text] [Related]
10. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs. Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI). Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539 [TBL] [Abstract][Full Text] [Related]
12. Amorphous stabilization of BCS II drugs using mesoporous silica. Tu B; Jonnalagadda S Int J Pharm; 2024 Sep; 663():124555. PubMed ID: 39111354 [TBL] [Abstract][Full Text] [Related]
13. Molecular states of prednisolone dispersed in folded sheet mesoporous silica (FSM-16). Nishiwaki A; Watanabe A; Higashi K; Tozuka Y; Moribe K; Yamamoto K Int J Pharm; 2009 Aug; 378(1-2):17-22. PubMed ID: 19465097 [TBL] [Abstract][Full Text] [Related]
14. Tadalafil inclusion in microporous silica as effective dissolution enhancer: optimization of loading procedure and molecular state characterization. Mehanna MM; Motawaa AM; Samaha MW J Pharm Sci; 2011 May; 100(5):1805-18. PubMed ID: 21374616 [TBL] [Abstract][Full Text] [Related]
15. Laser irradiation of BaMgHPO4 crystals in silica gel media at different growth environments (nucleation reduction strategy) and its characterization studies. Sundaramoorthi P; Kanchana G; Kalainathan S Spectrochim Acta A Mol Biomol Spectrosc; 2008 Apr; 69(4):1154-9. PubMed ID: 17686650 [TBL] [Abstract][Full Text] [Related]
17. Freezing and melting of water confined in silica nanopores. Findenegg GH; Jähnert S; Akcakayiran D; Schreiber A Chemphyschem; 2008 Dec; 9(18):2651-9. PubMed ID: 19035394 [TBL] [Abstract][Full Text] [Related]
18. Effect of water quenching and SiO2 addition during vitrification of fly ash Part 1: on the crystalline characteristics of slags. Kuo YM; Wang JW; Wang CT; Tsai CH J Hazard Mater; 2008 Apr; 152(3):994-1001. PubMed ID: 17766040 [TBL] [Abstract][Full Text] [Related]
19. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone. da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313 [TBL] [Abstract][Full Text] [Related]
20. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate. Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]